Silexion Therapeutics Ltd.
- SLXN
- NASDAQ
- Biotechnology
- RNAi Cancer Therapies
- LODER Drug Delivery Platform
$0.15
Quote Oct 19, 2026, 08:00 PM UTC
−64.87%over the last month
Max drawdown −71.9%From 1-month high −71.9%3 months −93.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Silexion Therapeutics
Silexion Therapeutics LTD is a biopharmaceutical company specializing in the discovery and advancement of RNA interference (RNAi)-based cancer therapies and their associated delivery systems, with a focus on treating aggressive solid tumors. The company's strategy for addressing these tumors relies on its proprietary LODER delivery platform.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
14
Founded
2008
Market value
$850,719.168
Quote Oct 19
Floor
$0.13
12.5% below price
Resistance
$0.17
11.8% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about SLXNPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free